» Articles » PMID: 35083504

A Predictive Nomogram for Intracerebral Hematoma Expansion Based on Non-contrast Computed Tomography and Clinical Features

Overview
Journal Neuroradiology
Specialties Neurology
Radiology
Date 2022 Jan 27
PMID 35083504
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To develop and validate a new nomogram utilizing non-contrast computed tomography (NCCT) signs and clinical factors for predicting hematoma expansion (HE) in patients with spontaneous intracerebral hemorrhage (ICH).

Methods: HE was defined as > 6 mL or 33% increase in baseline hematoma volume. Multivariable logistic regression analysis was performed to identify the predictors of HE. The discriminatory performance of the proposed model was evaluated via receiver operation characteristic (ROC) analysis, and the predictive accuracy was assessed by a calibration curve. The nomogram was established by R programming language. The decision curve analysis and clinical impact curve were drawn according to the related risk factors.

Results: A total of 506 patients with spontaneous ICH were recruited in the development cohort, and 103 patients were registered as the external validation cohort. Among the development cohort, 132 (26.09%) experienced HE. Glasgow coma scale (GCS) (P < 0.001), neutrophil to lymphocyte ratio (NLR) (P < 0.001), blend sign (P < 0.001), swirl sign (P < 0.001), and hypodensities (P = 0.003) were significant predictors of HE, by which were used to establish the nomogram. The model demonstrated good performance with high area under the curve both in the development (AUC = 0.908; 95% confidence interval, 0.880-0.936) and the external validation (AUC = 0.844; 95% confidence interval, 0.760-0.908) cohort. The calibration curve illustrated a high accuracy for HE prediction.

Conclusion: The nomogram derived from NCCT markers and clinical factors outperformed the NCCT signs-only model in predicting HE for patients with ICH, thus providing an effective and noninvasive tool for the risk stratification of HE.

Citing Articles

Machine learning for predicting hematoma expansion in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis.

Liu Y, Zhao F, Niu E, Chen L Neuroradiology. 2024; 66(9):1603-1616.

PMID: 38862772 DOI: 10.1007/s00234-024-03399-8.


A non-contrast computed tomography-based radiomics nomogram for the prediction of hematoma expansion in patients with deep ganglionic intracerebral hemorrhage.

Xu W, Guo H, Li H, Dai Q, Song K, Li F Front Neurol. 2022; 13:974183.

PMID: 36303563 PMC: 9592988. DOI: 10.3389/fneur.2022.974183.


Development and validation of a clinical-radiomics nomogram for predicting a poor outcome and 30-day mortality after a spontaneous intracerebral hemorrhage.

Xie Y, Chen F, Li H, Wu Y, Fu H, Zhong Q Quant Imaging Med Surg. 2022; 12(10):4900-4913.

PMID: 36185057 PMC: 9511432. DOI: 10.21037/qims-22-128.

References
1.
Brouwers H, Chang Y, Falcone G, Cai X, Ayres A, Battey T . Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol. 2013; 71(2):158-64. PMC: 4131760. DOI: 10.1001/jamaneurol.2013.5433. View

2.
Dowlatshahi D, Demchuk A, Flaherty M, Ali M, Lyden P, Smith E . Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011; 76(14):1238-44. PMC: 3068004. DOI: 10.1212/WNL.0b013e3182143317. View

3.
Salman R, Law Z, Bath P, Steiner T, Sprigg N . Haemostatic therapies for acute spontaneous intracerebral haemorrhage. Cochrane Database Syst Rev. 2018; 4:CD005951. PMC: 6494564. DOI: 10.1002/14651858.CD005951.pub4. View

4.
Anderson C, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C . Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013; 368(25):2355-65. DOI: 10.1056/NEJMoa1214609. View

5.
Qureshi A, Palesch Y, Barsan W, Hanley D, Hsu C, Martin R . Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med. 2016; 375(11):1033-43. PMC: 5345109. DOI: 10.1056/NEJMoa1603460. View